← FDA DRUG APPROVALS

FDA ANDA · ANDA077196

PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN

Sponsor: WATSON LABS FLORIDA

APPLICATION
ANDA077196
TYPE
ANDA
ORIGINAL APPROVAL
2005-06-28
LATEST ACTION
2005-06-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROPOXYPHENE NAPSYLATE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG, PROPOXYPHENE NAPSYLATE 100MG · TABLET · ORAL

Approval history

2005-06-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →